These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26871567)

  • 21. Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications.
    Torti C; Lapadula G; Izzo I; Brindicci G; Labbate G; Quiros-Roldan E; Diallo I; Gargiulo F; Castelnuovo F; Calabresi A; Carosi G; Manca N; Monno L
    Epidemiol Infect; 2010 Sep; 138(9):1298-307. PubMed ID: 20109261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008.
    Callegaro A; Svicher V; Alteri C; Lo Presti A; Valenti D; Goglio A; Salemi M; Cella E; Perno CF; Ciccozzi M; Maggiolo F
    Infect Genet Evol; 2011 Apr; 11(3):624-32. PubMed ID: 21292031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infrequent transmission of HIV-1 drug-resistant variants.
    Yerly S; Jost S; Telenti A; Flepp M; Kaiser L; Chave JP; Vernazza P; Battegay M; Furrer H; Chanzy B; Burgisser P; Rickenbach M; Gebhardt M; Bernard MC; Perneger T; Hirschel B; Perrin L;
    Antivir Ther; 2004 Jun; 9(3):375-84. PubMed ID: 15259900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting HIV Prevention Based on Molecular Epidemiology Among Deeply Sampled Subnetworks of Men Who Have Sex With Men.
    Wang X; Wu Y; Mao L; Xia W; Zhang W; Dai L; Mehta SR; Wertheim JO; Dong X; Zhang T; Wu H; Smith DM
    Clin Infect Dis; 2015 Nov; 61(9):1462-8. PubMed ID: 26129754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.
    Kouyos RD; von Wyl V; Yerly S; Böni J; Taffé P; Shah C; Bürgisser P; Klimkait T; Weber R; Hirschel B; Cavassini M; Furrer H; Battegay M; Vernazza PL; Bernasconi E; Rickenbach M; Ledergerber B; Bonhoeffer S; Günthard HF
    J Infect Dis; 2010 May; 201(10):1488-97. PubMed ID: 20384495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy.
    Lihana RW; Khamadi SA; Lubano K; Lwembe R; Kiptoo MK; Lagat N; Kinyua JG; Okoth FA; Songok EM; Makokha EP; Ichimura H
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1211-7. PubMed ID: 19954302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya.
    Hassan AS; Esbjörnsson J; Wahome E; Thiong'o A; Makau GN; Price MA; Sanders EJ
    PLoS One; 2018; 13(12):e0206177. PubMed ID: 30562356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
    Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
    Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity.
    Recordon-Pinson P; Anies G; Bruyand M; Neau D; Morlat P; Pellegrin JL; Groppi A; Thiébaut R; Dabis F; Fleury H; Masquelier B;
    Antivir Ther; 2009; 14(4):551-6. PubMed ID: 19578240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of clusters of CRF02_AG and B human immunodeficiency viral strains among men having sex with men exhibiting HIV primary infection in southeastern France.
    Tamalet C; Ravaux I; Moreau J; Brégigeon S; Tourres C; Richet H; Abat C; Colson P
    J Med Virol; 2015 Aug; 87(8):1327-33. PubMed ID: 25873310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach.
    Fisher M; Pao D; Brown AE; Sudarshi D; Gill ON; Cane P; Buckton AJ; Parry JV; Johnson AM; Sabin C; Pillay D
    AIDS; 2010 Jul; 24(11):1739-47. PubMed ID: 20588173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.
    Pandrea I; Robertson DL; Onanga R; Gao F; Makuwa M; Ngari P; Bedjabaga I; Roques P; Simon F; Apetrei C
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1103-16. PubMed ID: 12396449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype.
    Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Maciejewska K; Rymer W; Szymczak A; Szetela B; Gąsiorowski J; Bociąga-Jasik M; Skwara P; Garlicki A; Grzeszczuk A; Rogalska M; Jankowska M; Lemańska M; Hlebowicz M; Barałkiewicz G; Mozer-Lisewska I; Mazurek R; Lojewski W; Grąbczewska E; Olczak A; Jabłonowska E; Clark J; Urbańska A
    J Antimicrob Chemother; 2015 Jan; 70(1):233-42. PubMed ID: 25248322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subtype CRF01_AE dominate the sexually transmitted human immunodeficiency virus type 1 epidemic in Guangxi, China.
    Li L; Chen L; Liang S; Liu W; Li T; Liu Y; Li H; Bao Z; Wang X; Li J
    J Med Virol; 2013 Mar; 85(3):388-95. PubMed ID: 23341369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections.
    Pao D; Fisher M; Hué S; Dean G; Murphy G; Cane PA; Sabin CA; Pillay D
    AIDS; 2005 Jan; 19(1):85-90. PubMed ID: 15627037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High rates of forward transmission events after acute/early HIV-1 infection.
    Brenner BG; Roger M; Routy JP; Moisi D; Ntemgwa M; Matte C; Baril JG; Thomas R; Rouleau D; Bruneau J; Leblanc R; Legault M; Tremblay C; Charest H; Wainberg MA;
    J Infect Dis; 2007 Apr; 195(7):951-9. PubMed ID: 17330784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.
    Yang WL; Kouyos R; Scherrer AU; Böni J; Shah C; Yerly S; Klimkait T; Aubert V; Furrer H; Battegay M; Cavassini M; Bernasconi E; Vernazza P; Held L; Ledergerber B; Günthard HF;
    J Infect Dis; 2015 Jul; 212(1):28-38. PubMed ID: 25576600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV Type 1 transmission networks among men having sex with men and heterosexuals in Kenya.
    Bezemer D; Faria NR; Hassan A; Hamers RL; Mutua G; Anzala O; Mandaliya K; Cane P; Berkley JA; Rinke de Wit TF; Wallis C; Graham SM; Price MA; Coutinho RA; Sanders EJ
    AIDS Res Hum Retroviruses; 2014 Feb; 30(2):118-26. PubMed ID: 23947948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of HIV type 1 among HIV-infected respondents in a cohort being prepared for HIV Phase III vaccine clinical trials, Western Kenya.
    Oyaro M; Mbithi J; Oyugi F; Laten A; Anzala O; Engelbrecht S
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):257-64. PubMed ID: 20950148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.